Cargando…
Towards Circulating-Tumor DNA-Based Precision Medicine
In the era of precision medicine, targeted therapies have been implemented for various diseases. Genomic information guides decision-making in cancer treatment. The improvements in next-generation sequencing and polymerase chain reaction have made it possible to access the genetic information using...
Autores principales: | Hironaka-Mitsuhashi, Ai, Sanchez Calle, Anna, Ochiya, Takahiro, Takayama, Shin, Suto, Akihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780195/ https://www.ncbi.nlm.nih.gov/pubmed/31480647 http://dx.doi.org/10.3390/jcm8091365 |
Ejemplares similares
-
Long non‐coding NR2F1‐AS1 is associated with tumor recurrence in estrogen receptor‐positive breast cancers
por: Sanchez Calle, Anna, et al.
Publicado: (2020) -
MiR‐1285‐5p/TMEM194A axis affects cell proliferation in breast cancer
por: Hironaka‐Mitsuhashi, Ai, et al.
Publicado: (2020) -
Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision Medicine
por: Panagopoulou, Maria, et al.
Publicado: (2021) -
Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers
por: Cha, Yongjun, et al.
Publicado: (2023) -
Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers
por: Addanki, Sridevi, et al.
Publicado: (2022)